SWOT Analysis for Revolution Medicines Inc

Add SWOT widget to your site/app

PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Top Gainers
Stocks in uptrend most likely to cross above SMA-200 soon
Stock with Low PE (PE < = 10)
RSI indicating price strength

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Top Gainers

Stocks in uptrend most likely to cross above SMA-200 soon

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Declining profits every quarter for the past 4 quarters
Stocks Underperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Declining profits every quarter for the past 4 quarters

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Revolution Medicines Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Revolution Medicines Inc has 10 Strengths, 7 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Top Gainers

Stocks in uptrend most likely to cross above SMA-200 soon

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Declining profits every quarter for the past 4 quarters

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks